Related references
Note: Only part of the references are listed.Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach
Jeffrey J. Tosoian et al.
JOURNAL OF UROLOGY (2021)
Association Between Combined TMPRSS2: ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer
Martin G. Sanda et al.
JAMA ONCOLOGY (2017)
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2016)
Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
Gisele H. J. M. Leyten et al.
EUROPEAN UROLOGY (2014)
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
Simpa S. Salami et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Correlation of Urine TMPRSS2:ERG and PCA3 to ERG plus and Total Prostate Cancer Burden
Allison Young et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Quality-of-Life Effects of Prostate-Specific Antigen Screening
Eveline A. M. Heijnsdijk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Age-specific PCA3 score reference values for diagnosis of prostate cancer
Tobias Klatte et al.
WORLD JOURNAL OF UROLOGY (2012)
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Scott A. Tomlins et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up
Tineke Wolters et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment
Daniella Bianchi-Frias et al.
PLOS ONE (2010)
Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasia
Juan Morote et al.
WORLD JOURNAL OF UROLOGY (2010)
Rational Approach to Implementation of Prostate Cancer Antigen 3 Into Clinical Care
Rou Wang et al.
CANCER (2009)
Detection of prostate cancer in 2007 - Part 1: PSA and PSA kinetics
Fritz H. Schroder et al.
EUROPEAN UROLOGY (2008)
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
Jack Groskopf et al.
CLINICAL CHEMISTRY (2006)
The changing face of prostate cancer
MR Cooperberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
IM Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer
G Draisma et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Share Paper
